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Acute myocarditis presenting as acute coronary
syndrome: role of early cardiac magnetic resonance
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ABSTRACT
Background In patients presenting with acute cardiac
symptoms, abnormal ECG and raised troponin,
myocarditis may be suspected after normal angiography.
Aims To analyse cardiac magnetic resonance (CMR)
findings in patients with a provisional diagnosis of acute
coronary syndrome (ACS) in whom acute myocarditis
was subsequently considered more likely.
Methods and results 79 patients referred for CMR
following an admission with presumed ACS and raised
serum troponin in whom no culprit lesion was detected
were studied. 13% had unrecognised myocardial
infarction and 6% takotsubo cardiomyopathy. The
remainder (81%) were diagnosed with myocarditis.
Mean age was 45615 years and 70% were male. Left
ventricular ejection fraction (EF) was 58610%;
myocardial oedema was detected in 58%. A myocarditic
pattern of late gadolinium enhancement (LGE) was
detected in 92%. Abnormalities were detected more
frequently in scans performed within 2 weeks of
symptom onset: oedema in 81% vs 11% (p<0.0005),
and LGE in 100% vs 76% (p<0.005). In 20 patients with
both an acute (<2 weeks) and convalescent scan
(>3 weeks), oedema decreased from 84% to 39%
(p<0.01) and LGE from 5.6 to 3.0 segments (p¼0.005).
Three patients presented with sustained ventricular
tachycardia, another died suddenly 4 days after
admission and one resuscitated 7 weeks following
presentation. All 5 patients had preserved EF.
Conclusions Our study emphasises the importance of
access to CMR for heart attack centres. If myocarditis is
suspected, CMR scanning should be performed within
14 days. Myocarditis should not be regarded as benign,
even when EF is preserved.
INTRODUCTION
Contemporary strategies for managing patients
presenting with acute cardiac symptoms, an
abnormal ECG and raised serum troponin presume
a diagnosis of myocardial infarction (MI). Care
pathways implement rapid pharmacological and
percutaneous reperfusion therapy for acute coro-
nary syndrome (ACS). Urgent or emergency coro-
nary angiography conﬁrms the diagnosis and
percutaneous treatment is the standard of care.
However, in up to 10% of such patients at angi-
ography, no culprit coronary lesion is identiﬁed.1e3
Subsequently, the differential diagnosis includes
apparently non-signiﬁcant coronary disease
(including unstable plaque event, embolus, spasm
and ﬂush ostial occlusion of a branch artery), takot-
subo cardiomyopathy and myocarditis.4 Several
studies based on cardiac MRI5 6 and/or endomyo-
cardial biopsy7 demonstrate that the majority of
such patients have myocarditis. While the impor-
tance of secondary prevention of future coronary
events following ACS has been well deﬁned, the
prognosis ofmyocarditis presentingwith acute chest
pain in the absence of left ventricular (LV) systolic
impairment is not.8
Cardiac magnetic resonance (CMR) provides
structural and functional information, but is unique
in its ability to detect regional differences in
myocardial tissue characteristics. In this regard, late
imaging after gadolinium infusion may detect
regions of relative enhancement. Following a
myocardial infarction, a sub-endocardial or trans-
mural pattern of late enhancement is typical;
following myocarditis, late gadolinium enhance-
ment (LGE) is typically epicardial, in themid-wall or
patchy butmay also be transmural. Additionally, the
detection of increased regional myocardial T2 signal
indicates regional increases in water content infer-
ring inﬂammation.9 Together, LGE and T2 imaging
may reliably differentiate between MI and
myocarditis.5e7 10 11
In a high-volume heart attack centre, patients
admitted with an initial diagnosis of ACS that
subsequently had normal coronary angiography are
routinely referred for CMR imaging. We report our
experience and discuss the importance of this role for




The London Chest Hospital heart attack centre
provides assessment and treatment for patients
diagnosed with ACS in north-east London, a popu-
lation of 1.8 million. The centre manages approxi-
mately 650 patients with STelevation MI (STEMI)
and 1100 with non ST elevation MI (NSTEMI)
diagnoses each year. Between April 2008 and January
2010,we analysed the scans in all patients referred for
CMR following an acute admission with a provi-
sional diagnosis of ACS based on symptoms, raised
serum troponin and culprit lesion-free emergency
coronary angiography. We also studied patients who
did not undergo emergency angiography after similar
admissions because the admitting cardiologist
considered ACS had a low pretest probability.
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In a subset of patients, follow-up CMR scans were requested for
clinical indications, including the detection of widespread abnor-
malities on the initial scan, persistent symptoms or an uncertain
diagnosis following the ﬁrst scan.
Imaging protocol
All CMR studies were performed on a 1.5 T Philips Achieva
scanner with a cardiac 32-channel phased array coil. Balanced
steady-state free precession cine images were acquired with
25e30 phases/cycle and 8 mm slice thickness, 2 mm gap. Four-
chamber, two-chamber and LV inﬂow/outﬂow views and
a short-axis stack from mitral annulus to apex were obtained
(typical voxel size 1.931.9 mm). T2-weighted black-blood with
fat saturation (TSE-STIR) was performed in three short-axis
slices covering the basal, mid and apical myocardial segments
and in both 4-chamber and 2-chamber long axis (standard
imaging parameters include TR of 2 heart beats, TE 80 ms, in
plane voxel size 1.632.2 mm, slice thickness 8 mm, typical FOV
350 mm). T1 weighted inversion-recovery gradient echo images
were acquired 10 min after injection of a dose of 0.2 mmol/kg of
gadoterate meglumine (Dotarem) for LGE. Inversion time was
adjusted to null signal from healthy myocardium (voxel size
2.0732.16 mm, slice thickness 8 mm, FOV 300 mm).
All scans were reviewed independently by two CMR
accredited cardiologists. LV end diastolic (LVEDV) and end
systolic (LVESV) volumes and ejection fraction (LVEF) were
calculated according to previously described methods.12 Regional
wall motion abnormalities were assessed semi-quantitatively
and their distribution was reported according to the 17-segment
classiﬁcation of the American Heart Association. T2-weighted
images were assessed qualitatively. Areas of high signal intensity
were interpreted as myocardial oedema, and their distribution
was reported according to the 17-segment model.
LGE was assessed qualitatively and its distribution reported
according to the 17-segment model. A distribution of LGE
conﬁned to a sub-endocardial distribution was considered diag-
nostic for myocardial infarction (MI). Sub-epicardial, mid-wall
or patchy LGE was considered diagnostic for myocarditis in the
context of acute cardiac symptoms, raised serum troponin and
normal coronary angiography. Myocarditis was diagnosed if
transmural LGE was associated with histological evidence of
myocarditis, if a follow-up CMR scan demonstrated change
from a transmural into a sub-epicardial enhancement pattern, or
if the segmental distribution of LGE was not compatible with
a coronary territory.
Statistical analysis
Comparisons were made with paired and unpaired Student t
tests for continuous variables and the Fisher exact test for
categorical variables. Continuous variables were expressed as
mean6SD if normally distributed. A p value <0.05 was
considered signiﬁcant.
Consent and ethics
At the time of their scans, all patients consented to their




During the period of study, 1822 patients were admitted with
a diagnosis of acute coronary syndrome (779 with STEMI, 1043
with NSTEMI). Of these, 79 (4.3%) patients fulﬁlling criteria
were identiﬁed. Following the CMR scan, a diagnosis of MI or
cardiomyopathy was made in 15 patients (19%) who were
therefore excluded from further analysis. In 10 (13%) of these 15
patients, sub-endocardial or transmural LGE was observed in
a coronary distribution. A further 5 (6%) patients had typical
features of takotsubo cardiomyopathy. In the remaining
64 patients, a diagnosis of myocarditis was considered likely
(ﬁgure 1).
Demographic and clinical findings
The mean age of 64 patients with probable myocarditis was
45615 years (range 17e84); 70% were male. Serum troponin
was raised in every patient. The presenting symptom was
resting chest pain for the majority (91%). The clinical presen-
tation was life-threatening in ﬁve patients (8%): three were
admitted with sustained ventricular tachycardia (VT), another
died 4 days after admission and a ﬁfth re-presented with
sustained VT 7 weeks later. All had preserved LV systolic func-
tion. Urgent coronary angiography was obtained in 55 patients
(86%); 54 had unobstructed coronary arteries, and one patient
with moderate coronary stenosis had CMR features of
myocarditis and normal CMR stress perfusion imaging. In the
nine (14%) individuals that did not undergo emergency angi-
ography, the admitting cardiologist diagnosed pericarditis on the
basis of clinical features including young age, symptoms and
ECG changes. The mean age of patients not undergoing coro-
nary angiography was 2567 years (range 20e42; median 22) and
was lower than in those investigated by angiography
(49614 years, range 17e84, median 47; p<0.0001). CMR was
performed with a mean delay of 33 days (range 0e364; median
4) after onset of symptoms.
CMR findings
LV volumes and systolic function
End-diastolic volume was 150642 ml and end-systolic volume
was 65629 ml. The mean ejection fraction (EF) was 58610%
(range 29e79); a normal EF (>54%) was measured in 71%.
LV impairment was mild in 17% (EF 45e54%), moderate in
Figure 1 Flow chart demonstrating the final diagnoses in the study
cohort admitted with acute cardiac symptoms, raised serum troponin
and normal angiograms. CMR, cardiac magnetic resonance; MI,
myocardial infarction.
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10% (EF 30e44%) and severe in 2% (EF <30%).12 Regional wall
motion abnormalities were seen in 37% with a mean EF of
54610%; in 12 (52%) of these, the EF was in the normal range. A
pericardial effusion was detected in 10 (16%) patients.
T2 weighted imaging
T2 weighted imaging was obtained in 55 patients (86%) and
hyperintense signals compatible with oedema were detected in
32 (58%). The average number of affected myocardial segments
was 2.363.0 (range 0e13, median 1). Inferior, inferolateral and
apical segments were preferentially affected; hyperintense T2
signals were less frequently detected in the septal segments.
Figure 2A illustrates this pattern. All patients presenting with
hyperintense T2 weighted signal had LGE in the same segments.
Conversely, all patients with transmural LGE had evidence of co-
localised hyperintense T2 signal.
Late gadolinium enhancement
LGE imaging was performed in all patients and was abnormal in
59 (92%). When present, LGE was sub-epicardial in 33 (56%),
mid-wall in 9 (15%), patchy in 15 (25%) and transmural in 6
(10%). In one patient with transmural LGE, the distribution of
enhancement did not follow any coronary territory, involving
the anterior LV wall and the RV free wall, making it incom-
patible with a coronary injury. In a second patient with localised
transmural LGE, a scan 57 days later demonstrated regression of
transmural LGE to a typically epicardial myocarditic pattern. In
the third patient with transmural LGE, LGE was also distributed
in several myocardial segments, and giant cell myocarditis was
demonstrated at post-mortem examination (ﬁgure 3).
The number of affected myocardial segments was 4.363.9
(range 0e16; median 3) or 25% (range 0e94%; median 18%) of
the 17 segments. LGE was mainly observed in the inferior and
inferolateral walls as well as in the apical segments, and was less
commonly seen in the interventricular septum (ﬁgure 2A).
In 3 of 5 patients without LGE, the interval between symptom
onset and scan was prolonged (195e325 days). All three
presented with chest pain; two described recent viral illness and
had ST elevation on ECG consistent with pericarditis. A fourth
underwent scanning 30 days after presenting with chest pain.
The ﬁfth was scanned 24 days after presenting with pulmonary
oedema and a mild elevation in serum troponin; this patient had
received Adriamycin for breast cancer several years previously,
and had moderate global systolic impairment (EF 39%).
Effect of scan delay
We compared CMR ﬁndings between scans obtained within
2 weeks of presentation (n¼42, median interval¼3 days, range
0e10) with those obtained after this (n¼21, median inter-
val¼39 days, range 19e364). The ﬁndings are summarised in
table 1 and ﬁgures 2B and 4. There were no differences in EF or LV
dimensions. High T2 signal was detected in 81% of early
compared to 11% of late scans (p<0.0005), affecting 3.363.2
segments (range 0e13; median 3) compared to 0.361.0 (range
0e4; median 0; p<0.001). LGE was detected in 100% of early and
76% of late scans (p<0.005), affecting 5.364.2 segments (range
1e16; median 4) compared to 2.562.3 (range 0e8; median 2;
p<0.01). A pericardial effusion was seen in 8 (19%) in the group
scanned early and 2 (10%) in the group scanned later (NS).
Follow-up scan
Twenty patients underwent a follow-up CMR scan. The initial
scan was obtained with a mean delay of 4 days from presenta-
tion (range 0e10; median 3 days), and the follow-up scan was
performed 76 days following presentation (range 21e221;
median 45 days). The ﬁndings are summarised in table 2. There
was no difference in LV volumes but there was an increase in EF
(5969 vs 6268%, p<0.05).
The frequency of high T2 signal decreased from 84% in the
ﬁrst to 39% in the second scan (p<0.01) and the number of
affected segments decreased from 3.563.7 to 1.362.3 (p¼0.01).
The frequency of LGE was similar for both scans but the number
of affected segments decreased from 5.664.9 to 3.063.8
(p¼0.005). The distribution of LGE in the ﬁrst and second scans
is compared in ﬁgure 2C. We observed a consistent decrease in
the extent of LGE with time, as depicted in ﬁgure 5. A pericardial
effusion was present in ﬁve patients (25%) and persisted in four.
We next compared those patients with (n¼7) and without
(n¼11) persistently high T2 signal on follow-up scanning. The
delay between symptom onset and initial scan was similar (362
vs 363 days) but the delay to the follow-up scan was shorter in
the group with persistent oedema (39610, median 40 days vs
104679, median 46 days, p<0.05).
DISCUSSION
In our initial cohort of 79 patients, CMR performed within
2 weeks of presentation identiﬁes a likely aetiology in most cases
(ﬁgure 1). MI was diagnosed in 13% and stress cardiomyopathy
in 6%. These proportions are remarkably similar to the ﬁndings
Figure 2 Bull’s eye representation of myocardial involvement
according to the AHA 17 segments model in acute myocarditis. (A)
Relative frequency of segmental involvement of the myocardium with
hyperintense T2-signal (left) and late gadolinium enhancement (LGE)
(right) on initial scans. There is a preferential involvement of the inferior,
inferolateral and apical segments. (B) Segmental distribution of LGE on
initial scans performed <2 weeks (left) and >2 weeks (right) after
symptom onset. LGE is less frequently detected in scans performed
>2 weeks after symptom onset; there is still preferential involvement of
the inferior and inferolateral segments and the septal segments are very
infrequently involved. (C) Segmental distribution of LGE in initial scans
(<2 weeks; left) and convalescent scans (>3 weeks; right). There is
widespread myocardial involvement on the initial scans, with decrease
in LGE for all myocardial segments except the basal inferolateral
segment on convalescent scans.
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in three similar studies.5e7 Our analysis has concentrated on the
patients without CMR evidence of MI or cardiomyopathy; we
detected evidence of myocarditis in the majority (59/64 patients
(92%), representing 75% of the initial cohort). A ﬁnal diagnosis
was not made in only 5 (6%) of the original cohort.
Sensitivity and specificity of CMR for myocarditis
Published data on CMR ﬁndings in myocarditis are derived
mainly from small series including many patients with chronic
presentations of symptomatic LV systolic impairment. The
results of several such studies were used to generate recom-
mendations for the use of CMR in the evaluation of suspected
myocarditis.11 These studies were validated against either clin-
ical diagnosis or histological deﬁnitions of myocarditis. The
speciﬁcity of LGE for the diagnosis of myocarditis ranged
between 60% and 100% (pooled 86%) with the sensitivity far
lower, between 27% and 95% (pooled 59%). For T2 imaging, the
speciﬁcity was 50e100% (pooled 71%) and the sensitivity
45e100% (pooled 70%). When both T2 and LGE ﬁndings are
included, the pooled data from 130 patients was considered to
have a sensitivity of only 25%, but a speciﬁcity of 95%. Our
study suggests that the sensitivity is greatly increased in
patients presenting acutely with chest pain and raised cardiac
troponin if CMR is obtained immediately after symptom onset.
Other data support this view. Baccouche et al studied patients
with raised troponin and culprit-free angiograms with
a combined diagnostic approach using CMR (LGE but no T2
imaging) and myocardial biopsy.7 Patients with active
Figure 3 (A) Temporal evolution of the
distribution and severity of late
gadolinium enhancement (LGE) in acute
myocarditis. The initial scan (1 day
following admission) demonstrated
widespread enhancement with almost
transmural involvement of the septum
and lateral wall associated with
increased wall thickness. Basal
inferolateral hypokinesia was noted, but
left ventricular systolic function
preserved (ejection fraction (EF) 59%). A
repeat scan performed 1 month later
showed no regional motion
abnormalities and the myocardial wall
thickness had normalised. The LGE
enhancement remains evident in the
same myocardial segments as before,
but is clearly less severe. A third scan
performed at 5 months shows almost
complete resolution of septal LGE. The
pattern of LGE adopts a classic
myocarditic distribution, involving the
epicardial layers of the inferior and
lateral segments. (B) In another patient,
the acute phase CMR (top picture)
shows transmural LGE of the anterior
wall with epicardial enhancement of the
lateral and inferior walls. The basal
anterior wall is thickened and
hypokinetic but with preserved systolic
function (EF 57%). This patient died
suddenly 4 days after admission. The short-axis postmortem specimen corresponds approximately to the LGE image acquired 2 days earlier;
transmural necrosis of the anterior wall with subepicardial necrosis of the lateral and inferior wall is evident macroscopically, matching well with the
CMR images. Histology demonstrated myocyte necrosis, interstitial lymphocytic infiltration and giant cells (arrows); a diagnosis of giant cell
myocarditis was made.
Table 1 Cardiac magnetic resonance findings according to scan delay
<2 weeks (n[42) >2 weeks (n[21) p Value (unpaired)
Scan delay, median (days) 3 39
Age, mean6SD (years) 42615 52615 <0.05
Male gender, n (%) 64 81 NS
EDV, mean6SD (ml) 144643 162639 NS
ESV, mean6SD (ml) 61628 71631 NS
LVEF, mean6SD (%) 5968 58613 ns
RWMA, n (%) 38 33 ns
T2 hyperintense signal, n (%) 81 11 <0.0005
Number of segments, mean6SD 3.363.2 0.361.0 <0.0005
LGE, n (%) 100 76 <0.005
Number of segments, mean6SD 5.364.3 2.562.3 <0.01
EDV/ESV, end diastolic/systolic volume; LVEF, left ventricular ejection fraction; RWMA, regional wall motion abnormality; LGE, late
gadolinium enhancement.
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myocarditis as deﬁned by the Dallas criteria were more likely to
have abnormal LGE on CMR than those with borderline
myocarditis. Patients with LGE also had higher elevations of
serum creatine kinase.
Temporal dependence of high diagnostic sensitivity
The major contribution of the present study is the description
of the extent to which the diagnostic utility of CMR for
myocarditis is temporally dependent, and the importance of
CMR scanning in ‘real-world’ practice in a busy ACS centre.
Assomull et al report that CMR did not detect diagnostic
myocardial abnormalities in 35% in a similar cohort. After
excluding those patients with CMR evidence of MI or cardio-
myopathy, they detected LGE evidence of myocarditis in only
59% and T2 evidence in 37%. Laraudogoitia et al report these
abnormalities in 86% and 73%, respectively, of a similarly
deﬁned group, and our study detects abnormalities in 92% and
58%, respectively. These disparities may result from differences
in time between presentation and scan.
We demonstrate differences between early (<2 weeks) and
late CMR scans in sensitivity for the detection of the features of
myocarditis. Evidence for the temporal dependence of CMR’s
diagnostic utility is derived from an analysis of interval between
presentation and scan, and from a patient subset with serial
scans. When only early scans were analysed, LGE was detected
in all patients and T2 signals were abnormal in 81%. In the late
scans, abnormalities were detected in 75% and 12%, respectively.
In support of our ﬁndings, Laraudogoitia et al only detected
hyperintense regional T2 signals in scans performed within
7 days of presentation.6 LGE patterns also alter over time in two
important ways. First, a preference for lateral and apical
segments becomes more evident. Second, transmural LGE
resolves into a more subepicardial pattern (ﬁgure 3). Addition-
ally, as transmural LGE was invariably associated with high T2
signal, it is likely to reﬂect interstitial expansion with water and
does not reliably indicate regions of irreversible damage, as has
been suggested.13
Figure 4 Associations between the delay from presentation to cardiac
magnetic resonance (CMR) scanning and abnormal findings are shown
for all scans (the analysis includes all initial and convalescent scans;
n¼91 for late gadolinium enhancement (LGE) and n¼78 for T2). The
number of myocardial segments with LGE and focal hyperintense T2
signal are shown in (A) and (B), respectively. Myocardial involvement
appears to decrease with time; hyperintense T2 signals were unusual
>50 days after presentation.
Table 2 Cardiac magnetic resonance findings at initial and follow-up
scan (n¼20)
Initial Follow-up p Value (paired)
Scan delay, median (days) 3 45
EDV, mean6SD (ml) 148646 155637 NS
ESV, mean6SD (ml) 64632 61627 NS
LVEF, mean6SD (%) 5969 6268 <0.05
RWMA, n (%) 45 32 NS
T2 hyperintense signal, n (%) 84 39 <0.01
Number of segments, mean6SD 3.563.7 1.362.3 0.01
LGE, n (%) 100 95 NS
Number of segments, mean6SD 5.664.9 3.063.8 0.005
Figure 5 Reduction in the number of myocardial segments with high
T2 signal (A) and late gadolinium enhancement (LGE) (B) between acute
(<2 weeks) and convalescent (>3 weeks) scan for individual patients.
Mean values are depicted in red.
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Importance of the correct diagnosis of myocardial infarction
For patients presenting with acute cardiac symptoms, raised
serum troponin and no culprit coronary lesion, a recommenda-
tion that they receive lifelong secondary prevention is based on
the possibility that the acute event resulted from undetected
coronary disease.14 However, there is no evidence that lifelong
secondary treatment is warranted in the majority.
Contemporary secondary prevention regimes are associated
with major bleeding rates of 3.7% per annum or more,15 and
pharmacological costs are estimated to be >£700 in the ﬁrst year
alone (UK, 2010). The risks of recurrent coronary events
following denial of secondary prevention must also be balanced
against the ﬁnancial costs of complications, unnecessary treat-
ment, investigations, and costs of health and employment
insurance.
Importance of the correct diagnosis of myocarditis
Myocarditis presenting acutely with chest pain and normal LV
function is reported to be benign.8 Few, if any, studies provide
evidence for this view. The difﬁculty in establishing the diag-
nosis of myocarditis has undoubtedly contributed to the dearth
of outcome data.
Sub-group analyses of prospective ACS cohorts describe high
event rates, including death, in patients presenting with raised
troponin and unobstructed angiograms. A sub-study of
TACTICS-TIMI reports death, reinfarction or repeat hospital-
isation within 6 months of the initial presentation in 6.3% of
such patients.2 In those with normal angiograms and normal
troponin, the event rate was 2.7%. In a larger study, Larsen et al
report a 4% 1-year mortality in 273 patients with similar char-
acteristics.1 Our ﬁndings (and those of other reports5e7)are that
the majority of such patients have myocarditis. The high event
rate in our cohort is more direct evidence that this condition is
not benign.
Importance of serial scanning
Another novel observation is the additional speciﬁcity for
a diagnosis of myocarditis resulting from serial changes in CMR
abnormalities. In all cases where a second scan was performed,
resolution in severity, segmental distribution and transmurality
was evident (ﬁgures 3 and 5). Notably, in several cases where the
acute scan demonstrated transmural LGE, a regression to an
epicardial or mid-wall LGE lesion was evident in convalescent
images. In our opinion, when widespread or ﬂorid abnormalities
are present, their resolution on convalescent scanning provides
reassurance that the outcome is unlikely to be malignant.
Future directions
Myocarditis is diagnosed in up to 20% of cases of unexpected
sudden death,16e19 and viral myocarditis may be aetiologically
important in up to 60% of cases of dilated cardiomyopathy.20e22
In combination with clinical follow-up, CMR ﬁndings in the
acute and convalescent patient (such as ﬂorid or persistent high
T2 signal) presenting with ‘ACS’ myocarditis may contribute to
assessment of risks of both acute and long-term cardiac disease.
A multicentre myocarditis registry or a prospective study of
these patients may best provide the outcome data needed.
Clinical implications
The prognostic importance of the diagnosis of myocarditis in
this group of patients is currently undeﬁned. Future availability
of CMR in acute cardiac centres will generate a growing
uncertainty regarding the management of these patients that is
sustained by concerns that persistent inﬂammation may lead to
sudden death or systolic impairment. Our clinical management
following a CMR diagnosis of myocarditis is therefore based on
assessments intended to detect persistent inﬂammation or
progressive systolic impairment, and the international recom-
mendations for myocardial biopsy.23 Stable patients with
preserved LV systolic function and an unchanging 12-lead elec-
trocardiogram are discharged when serum troponin concentra-
tions begin to decline. All patients are rescanned 8 weeks
following the initial assessment and then reviewed as outpa-
tients. Cardiac biopsy is considered for those patients with
persistently raised cardiac troponin, impaired or worsening LV
systolic function or where T2 imaging suggests persistent
myocardial oedema. All patients are advised to avoid exercise
until after convalescent review and those with impaired LV
systolic function are considered for angiotensin converter
enzyme inhibitor and b-blocker therapy.
LIMITATIONS
Although this is not a prospective study of the utility of CMR in
culprit lesion-free ACS presentations with raised troponin, our
unit’s policy is to refer all such patients for CMR. In our study,
CMR interpretation is not blinded. However, the scan is inter-
preted for evidence of missed MI, myocarditis or any other
cardiac abnormalities. A blinded study would require the inter-
preting cardiologist to be blinded to a gold-standard diagnostic
test; cardiac biopsies were not obtained in this study, and are not
recommended for this indication.23
CONCLUSIONS
In acute myocarditis, CMR is more likely to detect diagnosti-
cally important evidence of myocardial damage if the scan is
performed within 2 weeks of presentation. The prognostic
importance of these abnormalities, their severity and any
persistence is unknown and merits further study. A repeat CMR
in selected individuals with equivocal early CMR ﬁndings after
4e6 weeks may be of diagnostic beneﬁt and, in patients with
very abnormal acute scans, improvements seen on follow-up
scans may provide reassurance. In those with systolic impair-
ment or when abnormal ﬁndings do not resolve, CMR targeted
cardiac biopsy could be considered. However, as sustained VT
and death occurred in the absence of signiﬁcant LV impairment,
myocarditis should not be considered benign when systolic
function is normal.
In patients presenting with chest pain, ECG changes, raised
troponin and apparently culprit-free coronary angiograms, CMR
frequently contributes to important diagnoses (including missed
MI) and may become an important component of diagnostic
pathways in heart attack centres. In considering indications for
secondary prevention following such admissions, CMR’s ability
to provide evidence for and against a diagnosis of missed MI may
provide substantial safety and cost beneﬁts.
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